A

Agilent Technologies, Inc. ·NYSE·Healthcare
149.33 live · 2026-08-13 15:59
43.4%
Brown Bear Score
49.3%
Business Conviction Score
56.0%
Position Health Score
55.8%
Chase Risk
Daily closes

Daily closes · 1Y (252 sessions) · +24.1% · range 110.24–157.20

The Businesswhat the company reports

Business & cash flow

FCF / assets 9.1%
OCF / assets 12.2%
FCF / revenue 22.4%
Gross margin 52.6%
ROIC 14.9%
Forward P/E 22.6

FCF/assets and OCF/assets are the cash-flow measures Brown Bear's own testing found to survive; FCF/revenue is shown alongside for context. Assets are from the latest annual filing (FY2025).

Price vs Earnings growth

Forward EPS growth has outpaced trailing price return by +8.6pp

Confidence 95.0/100

Takeaway Earnings growth is outpacing price — consistent with the stock not yet fully reflecting its improving forward estimates.

Reported earnings

Next report 2026-08-26 after the close · consensus EPS 1.52

Q3 23 revenue: 1.67bnQ3 23 net income: 111.00mQ3 23 EPS: 0.38Q4 23 revenue: 1.69bnQ4 23 net income: 475.00mQ4 23 EPS: 1.60Q4 23Q1 24 revenue: 1.66bnQ1 24 net income: 348.00mQ1 24 EPS: 1.18Q2 24 revenue: 1.57bnQ2 24 net income: 308.00mQ2 24 EPS: 1.05Q2 24Q3 24 revenue: 1.58bnQ3 24 net income: 282.00mQ3 24 EPS: 0.97Q4 24 revenue: 1.70bnQ4 24 net income: 351.00mQ4 24 EPS: 1.21Q4 24Q1 25 revenue: 1.68bnQ1 25 net income: 318.00mQ1 25 EPS: 1.11Q2 25 revenue: 1.67bnQ2 25 net income: 215.00mQ2 25 EPS: 0.75Q2 25Q3 25 revenue: 1.74bnQ3 25 net income: 336.00mQ3 25 EPS: 1.18Q4 25 revenue: 1.86bnQ4 25 net income: 434.00mQ4 25 EPS: 1.52Q4 25Q1 26 revenue: 1.80bnQ1 26 net income: 305.00mQ1 26 EPS: 1.07Q2 26 revenue: 1.83bnQ2 26 net income: 339.00mQ2 26 EPS: 1.20Q2 26

Revenue Net incomeEPS (GAAP) (0.38–1.60, own scale) Derived Q4

12 quarters to Q2 26. Revenue and net income share one scale, so the gap between them is the margin. The line is GAAP EPS — it spans every quarter shown, where the reported figure only goes back as far as the consensus feed does.

Quarter endingRevenueYoY Net incomeEPS (GAAP) Filed
2026-04-30 1.83bn +10.0% 339.00m 1.20 2026-06-01
2026-01-31 1.80bn +7.0% 305.00m 1.07 2026-03-03
2025-10-31 (derived) 1.86bn +9.4% 434.00m 1.52 2025-12-22
2025-07-31 1.74bn +10.1% 336.00m 1.18 2025-08-29

Earnings response

Typical move around a filing ±0.9%
On an ordinary two days ±1.4% — filings move it 0.7× as much
Direction 6 up, 6 down over 12 filings
Revenue change and price reaction, by quarter
Q3 22 revenue +8.3% year on yearQ3 22 filed 2022-09-01: price -0.2%Q1 23 revenue +4.9% year on yearQ1 23 filed 2023-03-03: price +1.1%Q1 23Q2 23 revenue +6.8% year on yearQ2 23 filed 2023-05-26: price -1.5%Q3 23 revenue -2.7% year on yearQ3 23 filed 2023-08-31: price -0.6%Q3 23Q1 24 revenue -5.6% year on yearQ1 24 filed 2024-03-05: price +2.4%Q2 24 revenue -8.4% year on yearQ2 24 filed 2024-06-03: price +0.3%Q2 24Q3 24 revenue -5.6% year on yearQ3 24 filed 2024-08-30: price -2.5%Q1 25 revenue +1.4% year on yearQ1 25 filed 2025-03-03: price -3.8%Q1 25Q2 25 revenue +6.0% year on yearQ2 25 filed 2025-06-02: price +0.8%Q3 25 revenue +10.1% year on yearQ3 25 filed 2025-08-29: price +0.2%Q3 25Q1 26 revenue +7.0% year on yearQ1 26 filed 2026-03-03: price +2.0%Q2 26 revenue +10.0% year on yearQ2 26 filed 2026-06-01: price -0.4%Q2 26

Revenue up year on year Revenue down Price move around the filing separate scales — a crossing means nothing

Quarter endingFiledRevenue YoY Move around filingNext 20 sessions vs SPY
2026-04-30 2026-06-01 +10.0% -0.4% +0.5%
2026-01-31 2026-03-03 +7.0% +2.0% -0.7%
2025-07-31 2025-08-29 +10.1% +0.2% -1.6%
2025-04-30 2025-06-02 +6.0% +0.8% +2.8%

Share count

Diluted shares over time

Diluted shares Return since the previous filing

Direction Flat — little net change
Diluted shares 283.0M as at 2026-04-30
Change over 1 year -0.7%
Change over 3 years -4.7%
Public float $26.60bn as at 2025-04-30 (10-K)

The Pricewhat the chart is doingTop ↑

Price Levels

StrategyFair Value Anchor
Reference band 139.68 — 150.04
Protective stop 136.85 (Atr, 5.5% risk)
Support 135.96 (2 touches, 9.8% away)
Resistance 150.17 (0.6% away)

Takeaway The shares are nearer the ceiling than the floor: about 0.6% below 150.17, where sellers have turned up before, and 9.8% above 135.96, where buyers have stepped in before. That floor has held 2 times, which is how it was spotted. If someone bought at today's price and sold if it dropped through the level below, they would be about 5.5% out of pocket. That is all this figure means — an illustration of the risk, not a price to sell at.

Levels are computed from price structure. They describe where the engine locates support and extension — they are not targets, and not advice.

Ichimoku Cloud (Adaptive)

Daily cloudPrice ABOVE the cloud | periods 9/26/52 (100% of classic 9/26/52)
LinesTenkan/Kijun BULL | cloud twist BULL
Cloud thickness32% percentile (thin — little structure to fight through)
Chikou spanAbove price from 26 periods ago
Weekly cloudPrice ABOVE the weekly cloud (context only, not scored)

Takeaway The stock is trading above its cloud — a shaded band drawn from several of its own moving averages, currently 136.97 to 141.83. Being above it means the medium-term picture is pointing upwards, and that band is the first place the stock has recent support if it slips back. Its shorter-term averages agree with that.

Trailing returns

21 days +10.8%
63 days +32.4%
126 days +15.8%
252 days +27.3%
Below 252d high5.0%

Trend context

PositionFar above trend
ExtensionExtremely extended
Trend slopeRising
Direction of travelHolding its deviation

Takeaway Extreme upside extension above Kalman fair trend; entry risk is elevated.

Volatility

State Expanding
Current band width16.4% of price
Recent tightest9.7% (6 sessions ago, narrower than 75.0% of its history)
Expansion since1.70×
Band 128.74 — 151.79

Takeaway Lately this share price has been swinging around inside a range roughly 16% wide. That is normal for this stock, so there is nothing unusual to read into it either way.

Historical trends

0255075100Share price 129.07–149.492026-07-032026-08-13
Position Health Business Conviction Share price

History begins when the site started recording, not when the company listed, so a short line means a short record and nothing more.

Repair Pathway

  1. Nearest Trigger Volume confirmation above 1.2x +0.20x volume confirmation would improve confidence in the pathway · Broadly stable

Who's Tradingthe flow behind the priceTop ↑

Insider activity

ActivityInsider selling
Buy filings0
Sell filings1
Shares sold1,600
Value sold$216.7k
Latest sell2026-05-29
FiledInsiderSharesValue
2026-05-29 Sold Dolsten MikaelDirector 1,600 $216,672

Open-market Form 4 purchases and sales over the last 75 days, read from SEC EDGAR Form 4. Grants, option exercises, gifts and shares withheld for tax are excluded — they are compensation mechanics, not a decision to buy or sell. Reported Form 4 activity. Brown Bear tested insider cluster-buying as a return signal and rejected it as era-unstable; shown as fact, not signal.

Volume confirmation

Volume-price trend Above its signal line
Confirmation Marginal

No absorption or distribution event in the recent window.

Takeaway Slightly more shares change hands on rising days than on falling ones, but the gap is too small to read anything into.

Options Positioning

No binary-event flag

A: no binary-event flag. Near IV 30%, far IV 34% (ratio 0.90), implied move 3.6%.

Implied volatility 30% near (8d) · 34% far (64d)
Term structure 0.90× near/far
Historical volatility 28%
Implied vs historical 1.08×
Implied move ±3.6% by 2026-08-21
Implied move vs ATR 0.59×
Skew Flat (1.02×)
Call wall 160.00 (+7.2% away)
Put wall 130.00 (-12.9% away)
Gamma pin 135.00

Takeaway Insuring against a move in this stock costs less for the next few weeks than for the next few months, which is the normal state of affairs and suggests no particular date is worrying anyone. Options traders are positioned for a move of around 3.6% in either direction by 2026-08-21.

Chain as at 2026-08-13. This is a risk read on whether a specific event is being priced — not a directional view.

Context & Methodthe record, and how it was builtTop ↑

Relative Rotation

ImprovingLeadingLaggingWeakeningvs sectorvs SPYsector vs SPYRS-Ratio →RS-Momentum →

Mixed Rotation Phase

Rotation health 46.2/100; Mixed Rotation.

Rotation health 46.2
Rotation strength 81.5
LegQuadrantRS-RatioRS-Mom
Stock vs sector Weakening 118.0 74.4
Stock vs SPY Weakening 112.8 86.0
Sector vs SPY Lagging 86.4 99.4

Direction of travel: South-East / trend strong but momentum cooling

Position only. Brown Bear's RRG redesign programme is closed — five constructions, none beat an appropriate null — so this section describes where the name sits, and is not a signal.

News Headlines

  1. Loading headlines\u2026

Headlines are supplied by third-party feeds and are not written, ranked or interpreted by Brown Bear. They feed no score on this page.

Detailed Scoring

Positive signals

  • Piotroski F-score 5/9 (+10.0)
  • Altman Z-score 8.71 (+10.0)
  • Insider conviction score (+3.0)
  • Gross margin quality: 52.6% (+12.0)
  • ROIC quality: 14.9% (+8.5)
  • FCF margin quality: 22.4% (+15.0)
  • FCF margin improving by -4.5 pts (+-3.0)
  • High earnings quality (accrual ratio -0.020) (+2.0)
  • Relative Strength 9.0% vs sector: OUTPERFORMING (+10.0)
  • Track 1: MACD histogram state (0.85) (+6.0)
  • Track 1: relative strength trend improving (+5.0)
  • Track 1: 20-day momentum acceleration 0.04 (+3.0)
  • Track 1: bullish DI spread 17.7 (+5.0)
  • Track 1: ADX 22.5 and rising (+5.0)
  • Track 1: relative momentum rank 0.68 (+2.5)
  • Track 1: EMA20 reclaim distance 5.4% (+3.7)
  • Track 1: EMA20 slope improving 3.2% (+5.0)
  • Track 1: MACD histogram acceleration 0.65 (+7.0)
  • Track 1: positive MACD regime (+3.0)
  • Track 1: MACD line/signal repair quality (+8.0)
  • Track 1: MACD slope improving (+5.0)
  • Track 1: VPT strength 0.09 (+1.8)
  • Track 1: price above EMA50 by 10.1% (+5.0)
  • Track 1: EMA50 slope improving 3.4% (+3.0)
  • Track 1: Bollinger position 0.89 (+0.9)

Negative signals

  • Track 1: weak volume confirmation (0.40x average)
  • Track 1: RSI deterioration/extension 76.6, 5-day change +3.7
  • Chase risk 55.8/100 (Elevated Chase Risk): RSI 76.6, EMA20 5.4%, EMA50 10.1%, BB 0.89, distribution 9.0/100
  • Gross margin improving by -1.7 pts (+-3.0)
  • ROIC improving by -1.4 pts (+-5.0)
  • Chase risk 55.8/100 | Extension score 44.2/100 | Elevated Chase Risk